The Influence of Covid-19 on the Audio-vestibular System

NCT ID: NCT04709146

Last Updated: 2021-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the study's porpuse is to examine whether Covid-19 causese a reduction in sensorineural hearing and vestibular function in recovered pateints - compared to healthy controls.

Both study groups will undergo audiometry, tympanometry, Video Head Impulse testing, Subjective Visual Vertigo testing and Video-Nystamography.

Previous audiometry results will also be aquired.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Recovered Covid-19 patients

Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG.

Group Type OTHER

Audio-Vestibular evaluation

Intervention Type DIAGNOSTIC_TEST

Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG.

Healthy Control

Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG.

Group Type OTHER

Audio-Vestibular evaluation

Intervention Type DIAGNOSTIC_TEST

Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Audio-Vestibular evaluation

Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ages 18-80 performed audiometry testing in the last two years

Exclusion Criteria

* known inner ear dysfunction - Sudden sensorineural hearing loss; autoimmune disease (Cogan's syndrom, SLE, ect.), familial/genetic sensorineural hearing loss, excessive noise exposure.

knowm conductive hearing loss (Air-bone gap\>10dB) prior ear surgery chronic tympanic membrane perforation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HaEmek Medical Center, Israel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yoni Evgeni Gutkovich

M.D/Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yoni Evgeni Gutkovich, M.D/Ph.D

Role: CONTACT

+972-526894497

Miki Paker, M.D

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0226-20-EMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effects of Chronic Otitis Surgery on SVV
NCT04396145 ACTIVE_NOT_RECRUITING
OTO-104 for Meniere's Disease
NCT01084525 COMPLETED PHASE1